ORIGINAL RESEARCH
Published on 01 Dec 2025
The value of 18F-FDG PET/CT imaging in predicting the efficacy of PD-1/PD-L1 immune checkpoint inhibitors in advanced non-small cell lung cancer
doi 10.3389/fonc.2025.1651843
- 764 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Development and Validation of New Molecular Probes of Nuclear Medicine and New Targets of Nuclear Drugs in Cancers
Development and Validation of New Molecular Probes of Nuclear Medicine and New Targets of Nuclear Drugs in Cancers
3,260
Total downloads
23k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 29 Oct 2025
Experimental study on the treatment of norepinephrine transporter-overexpressing pheochromocytomas and paragangliomas: a synthetic lethality strategy combining 131I-MIBG with PARP inhibitors
doi 10.3389/fonc.2025.1681054
- 510 views
ORIGINAL RESEARCH
Published on 25 Sep 2025
Clozapine is responsible for the in vivo imaging and pharmacological effects of clozapine-N-oxide in murine DREADD models
doi 10.3389/fphar.2025.1671065
- 1,171 views
ORIGINAL RESEARCH
Published on 28 Aug 2025
Role of 18F-AlF-NOTATATE PET/CT in selecting pediatric neuroblastoma candidates for 177Lu-DOTATATE peptide receptor radionuclide therapy
doi 10.3389/fmed.2025.1615136
- 3,143 views
ORIGINAL RESEARCH
Published on 03 Jul 2025
The value of 18F-AlF-NOTATATE PET/CT in restaging high-risk neuroblastoma after chemotherapy
doi 10.3389/fmed.2025.1596272
- 1,693 views
ORIGINAL RESEARCH
Published on 04 Jun 2025
SPAG6 Promotes Multiple Myeloma Through Activation of the MAPK/ERK Signaling Pathway
doi 10.3389/fphar.2025.1572621
- 1,386 views
- 1 citation
ORIGINAL RESEARCH
Published on 15 May 2025
Preclinical studies of a PARP-targeted theranostic radiopharmaceutical for pancreatic cancer
doi 10.3389/fphar.2025.1576587
- 1,618 views
- 1 citation
REVIEW
Published on 14 May 2025
Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy
doi 10.3389/fphar.2025.1593380
- 4,383 views
REVIEW
Published on 08 May 2025
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives
doi 10.3389/fphar.2025.1559236
- 3,327 views
ORIGINAL RESEARCH
Published on 10 Apr 2025
Predictive significance of 18F-FDG PET/CT metabolic parameters for the expression level of HER2 in gastric cancer
doi 10.3389/fonc.2025.1580166
- 1,283 views
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Other participating journals
Frontiers in Medicine
- 3.0 impact factor
- 6.0 citescore
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore